Vivos Therapeutics Shares Rise After Medicare Approval for VidaSleep

Dow Jones

Jul 02

By Chris Wack

Vivos Therapeutics shares were 24% higher, at $3.91, after the company said its VidaSleep oral appliance was approved by the Centers for Medicare & Medicaid Services Pricing, Data Analysis and Coding contractor for treatment of mild to moderate obstructive sleep apnea and snoring in adults.

The Littleton, Colo., medical-technology company said on Tuesday that VidaSleep features its Unilateral Bite Block technology, which is patented and has been cleared by the Food and Drug Administration.

Medicare coverage opens the door to commercial payers that follow CMS guidelines, increasing Vivos' addressable market, Vivos said.

With this approval, Vivos said, VidaSleep joins its mmRNA on the Pricing, Data Analysis and Coding list of covered oral appliances, unlocking access for millions of Medicare beneficiaries.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

July 01, 2025 13:58 ET (17:58 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2548881360"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548881360\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2548881360?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-02 01:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548881360","market":"fut","top_or_hot":-1,"title":"Vivos Therapeutics Shares Rise After Medicare Approval for VidaSleep","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/VVOS\">Vivos Therapeutics</a> shares were 24% higher, at $3.91, after the company said its VidaSleep oral appliance was approved by the Centers for Medicare &amp; Medicaid Services Pricing, Data Analysis and Coding contractor for treatment of mild to moderate obstructive sleep apnea and snoring in adults. \n</p>\n<p>\n  The Littleton, Colo., medical-technology company said on Tuesday that VidaSleep features its Unilateral Bite Block technology, which is patented and has been cleared by the Food and Drug Administration. \n</p>\n<p>\n  Medicare coverage opens the door to commercial payers that follow <a href=\"https://laohu8.com/S/8A8.SI\">CMS</a> guidelines, increasing Vivos' addressable market, Vivos said. \n</p>\n<p>\n  With this approval, Vivos said, VidaSleep joins its mmRNA on the Pricing, Data Analysis and Coding list of covered oral appliances, unlocking access for millions of Medicare beneficiaries. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 01, 2025 13:58 ET (17:58 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vivos Therapeutics Shares Rise After Medicare Approval for VidaSleep</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVivos Therapeutics Shares Rise After Medicare Approval for VidaSleep\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-02 01:58</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/VVOS\">Vivos Therapeutics</a> shares were 24% higher, at $3.91, after the company said its VidaSleep oral appliance was approved by the Centers for Medicare &amp; Medicaid Services Pricing, Data Analysis and Coding contractor for treatment of mild to moderate obstructive sleep apnea and snoring in adults. \n</p>\n<p>\n  The Littleton, Colo., medical-technology company said on Tuesday that VidaSleep features its Unilateral Bite Block technology, which is patented and has been cleared by the Food and Drug Administration. \n</p>\n<p>\n  Medicare coverage opens the door to commercial payers that follow <a href=\"https://laohu8.com/S/8A8.SI\">CMS</a> guidelines, increasing Vivos' addressable market, Vivos said. \n</p>\n<p>\n  With this approval, Vivos said, VidaSleep joins its mmRNA on the Pricing, Data Analysis and Coding list of covered oral appliances, unlocking access for millions of Medicare beneficiaries. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 01, 2025 13:58 ET (17:58 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VVOS","symbol_name":"Vivos Therapeutics","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2548881360","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548881360","pubTimestamp":1751392680,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Vivos Therapeutics shares were 24% higher, at $3.91, after the company said its VidaSleep oral appliance was approved by the Centers for Medicare & Medicaid Services Pricing, Data Analysis and Coding contractor for treatment of mild to moderate obstructive sleep apnea and snoring in adults.The Littleton, Colo., medical-technology company said on Tuesday that VidaSleep features its Unilateral Bite Block technology, which is patented and has been cleared by the Food and Drug Administration.Medicare coverage opens the door to commercial payers that follow CMS guidelines, increasing Vivos' addressable market, Vivos said.With this approval, Vivos said, VidaSleep joins its mmRNA on the Pricing, Data Analysis and Coding list of covered oral appliances, unlocking access for millions of Medicare beneficiaries.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VVOS":"Vivos Therapeutics","BK4196":"保健护理服务"},"translate_title":"Vivos Therapeutics股价在Medicare批准VidaSleep后上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VVOS":1},"content_text":"By Chris Wack \n\n\n \n\n\nVivos Therapeutics shares were 24% higher, at $3.91, after the company said its VidaSleep oral appliance was approved by the Centers for Medicare & Medicaid Services Pricing, Data Analysis and Coding contractor for treatment of mild to moderate obstructive sleep apnea and snoring in adults. \n\n\n  The Littleton, Colo., medical-technology company said on Tuesday that VidaSleep features its Unilateral Bite Block technology, which is patented and has been cleared by the Food and Drug Administration. \n\n\n  Medicare coverage opens the door to commercial payers that follow CMS guidelines, increasing Vivos' addressable market, Vivos said. \n\n\n  With this approval, Vivos said, VidaSleep joins its mmRNA on the Pricing, Data Analysis and Coding list of covered oral appliances, unlocking access for millions of Medicare beneficiaries. \n\n\n \n\n\n  Write to Chris Wack at chris.wack@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 01, 2025 13:58 ET (17:58 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}